Dysfunction of peripheral blood dendritic cells from patients with chronic hepatitis B virus infection
Open Access
- 1 January 2001
- journal article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 7 (4), 537-41
- https://doi.org/10.3748/wjg.v7.i4.537
Abstract
AIM: To identify the property of dendritic cells (DCs) of peripheral blood monocytes (PBMC) in patients with chronic HBV infection. METHODS: Twenty patients with persistent HBV infection were included in this study, 10 healthy subjects being used as a control group. The peripheral blood mononuclear cells (PBMC) of T cell-depleted populations were incubated and induced into mature dendritic cells in the RPMI-1640 medium in the presence of cytokines GM-CSF, IL-4, FLt-3, TNF-α and 100 mL·L-1 of fetal calf serum for a total of 10-12 d. The expressions of surface markers on DCs were evaluated using flow cytometric analysis. ELISA method was used to determine the cytokine levels of interleukin-12 (IL-12) and IL-10 in the supernatant produced by DCs. For detection of the stimulatory capacity of DCs to T cell proliferation, mytomycin C-treated DC were incubated with allogenic T cells. RESULTS: A typical morphology of mature DCs from healthy subjects and HBV-infected patients was induced in in vitro incubation, but the proliferation ability and cellular number of DCs from HBV-infected patients significantly decreased compared with healthy individuals. In particular, the expression levels of HLA-DR, CD80 (B7-1) and CD86 (B7-2) on DC surface from patients were also lower than that from healthy individuals (0.46 vs 0.92 for HLA-DR, 0.44 vs 0.88 for CD80 and 0.44 vs 0.84 for CD86, P < 0.05). The stimulatory capacity and production of IL-12 of DCs from patients in allogenic mixed lymphocyte reaction (AMLR) significantly decreased, but the production level of nitric oxide (NO) by DCs simultaneously increased compared with healthy subjects (86 ± 15 vs 170 ± 22 μmol·L-1, P < 0.05). CONCLUSION: The patients with chronic HBV infection have the defective function and immature phenotype of dendritic cells, which may be associated with the inability of efficient presentation of HBV antigens to host immune system for the clearance of HBV.Keywords
This publication has 25 references indexed in Scilit:
- Chronic viral hepatitis and the human genomeHepatology, 2000
- Viral Clearance Without Destruction of Infected Cells During Acute HBV InfectionScience, 1999
- Low Stimulatory Capacity of Lymphoid Dendritic Cells Expressing Hepatitis C Virus GenesBiochemical and Biophysical Research Communications, 1998
- Molecular Analysis of Decreased Interleukin-12 Production in Persons Infected with Human Immunodeficiency VirusThe Journal of Infectious Diseases, 1996
- New insights into the mobilization and phagocytic activity of dendritic cells.The Journal of Experimental Medicine, 1996
- Hepatitis B Virus ImmunopathogenesisAnnual Review of Immunology, 1995
- Interleukin 12 induces the differentiation of major histocompatibility complex class I-primed cytotoxic T-lymphocyte precursors into allospecific cytotoxic effectors.Proceedings of the National Academy of Sciences of the United States of America, 1994
- Proliferating dendritic cell progenitors in human blood.The Journal of Experimental Medicine, 1994
- Impaired interleukin 12 production in human immunodeficiency virus-infected patients.The Journal of Experimental Medicine, 1994